MARIMED INC.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $159.8M | $157.7M | $148.6M | $134.0M | $121.5M | $50.9M | $45.6M | $11.9M |
| Cost of Revenue | $101.9M | $95.1M | $82.7M | $70.1M | $55.2M | $19.6M | $26.9M | $4.0M |
| Gross Profit | $57.9M | $62.6M | $65.9M | $64.0M | $66.3M | $31.3M | $18.7M | $7.8M |
| Gross Margin | 36.2% | 39.7% | 44.4% | 47.7% | 54.6% | 61.5% | 41.0% | 65.9% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $26.1M | $25.6M | $22.1M | $20.7M | $27.6M | $9.9M | $8.8M | $10.1M |
| Operating Income | $-2.8M | $2.6M | $14.4M | $20.4M | $26.9M | $14.5M | $-41.5M | $-5.4M |
| Operating Margin | -1.8% | 1.7% | 9.7% | 15.2% | 22.1% | 28.6% | -91.1% | -45.2% |
| Interest Expense | — | — | $9.2M | $1.7M | $2.4M | $9.8M | $12.7M | $4.4M |
| Pretax Income | $-10.9M | $-4.3M | $-6.6M | $19.5M | $23.8M | $4.5M | $-81.8M | — |
| Income Tax Expense | $3.6M | $8.2M | $9.4M | $5.9M | $16.2M | $2.1M | $67.2K | — |
| Net Income | $-14.5M | $-12.5M | $-16.0M | $13.5M | $7.2M | $2.1M | $-81.2M | $-13.6M |
| Net Margin | -9.1% | -7.9% | -10.8% | 10.0% | 5.9% | 4.2% | -178.0% | -114.8% |
| EPS (Basic) | $-0.04 | $-0.03 | $-0.04 | $0.04 | $0.02 | $0.01 | $-0.39 | $-0.07 |
| EPS (Diluted) | $-0.04 | $-0.03 | $-0.04 | $0.04 | $0.02 | $0.01 | $-0.39 | $-0.07 |
| Shares Outstanding (Basic) | 390.1M | 379.2M | 363.4M | 337.7M | 326.5M | 267.0M | 208.7M | 211.0M |
| Shares Outstanding (Diluted) | 390.1M | 379.2M | 363.4M | 380.3M | 372.4M | 324.2M | 208.7M | 211.0M |
| Dividends Per Share | — | — | — | — | — | — | — | — |